Atlas Trials

Phase 3 IGIV, 10% in Alzheimer´s Disease

Clinical trial NCT01524887 · TERMINATED

Trial details

NCT number
NCT01524887
Sponsor
Baxalta now part of Shire
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer´s Disease
Start date
2012-01-23
Primary completion
2013-07-16
Enrollment
508

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.